300 related articles for article (PubMed ID: 18272255)
41. First synthesis of an aziridinyl fused pyrrolo[1,2-a]benzimidazole and toxicity evaluation towards normal and breast cancer cell lines.
Bonham S; O'Donovan L; Carty MP; Aldabbagh F
Org Biomol Chem; 2011 Oct; 9(19):6700-6. PubMed ID: 21808774
[TBL] [Abstract][Full Text] [Related]
42. Synthesis, characterization and evaluation of benzimidazole derivative and its precursors as inhibitors of MDA-MB-231 human breast cancer cell proliferation.
Thimmegowda NR; Nanjunda Swamy S; Kumar CS; Kumar YC; Chandrappa S; Yip GW; Rangappa KS
Bioorg Med Chem Lett; 2008 Jan; 18(1):432-5. PubMed ID: 17981032
[TBL] [Abstract][Full Text] [Related]
43. Benzimidazol-2-ylidene gold(I) complexes are thioredoxin reductase inhibitors with multiple antitumor properties.
Rubbiani R; Kitanovic I; Alborzinia H; Can S; Kitanovic A; Onambele LA; Stefanopoulou M; Geldmacher Y; Sheldrick WS; Wolber G; Prokop A; Wölfl S; Ott I
J Med Chem; 2010 Dec; 53(24):8608-18. PubMed ID: 21082862
[TBL] [Abstract][Full Text] [Related]
44. Design, synthesis, and cytotoxic evaluation of a new series of 3-substituted spiro[(dihydropyrazine-2,5-dione)-6,3'-(2',3'-dihydrothieno[2,3-b]naphtho-4',9'-dione)] derivatives.
Gomez-Monterrey I; Campiglia P; Carotenuto A; Califano D; Pisano C; Vesci L; Lama T; Bertamino A; Sala M; di Bosco AM; Grieco P; Novellino E
J Med Chem; 2007 Apr; 50(8):1787-98. PubMed ID: 17375902
[TBL] [Abstract][Full Text] [Related]
45. Antihelminthic activity of some newly synthesized 5(6)-(un)substituted-1H-benzimidazol-2-ylthioacetylpiperazine derivatives.
Mavrova ATs; Anichina KK; Vuchev DI; Tsenov JA; Denkova PS; Kondeva MS; Micheva MK
Eur J Med Chem; 2006 Dec; 41(12):1412-20. PubMed ID: 16996654
[TBL] [Abstract][Full Text] [Related]
46. Synthesis and anticancer activity of some 1,2,3-trisubstituted pyrazinobenzimidazole derivatives.
Demirayak Ş; Yurttaş L
J Enzyme Inhib Med Chem; 2014 Dec; 29(6):811-22. PubMed ID: 24456294
[TBL] [Abstract][Full Text] [Related]
47. Novel benzimidazole-pyrimidine conjugates as potent antitumor agents.
Abdel-Mohsen HT; Ragab FA; Ramla MM; El Diwani HI
Eur J Med Chem; 2010 Jun; 45(6):2336-44. PubMed ID: 20356655
[TBL] [Abstract][Full Text] [Related]
48. Synthesis, structure and biological activities of cobalt(II) and zinc(II) coordination compounds with 2-benzimidazole derivatives.
López-Sandoval H; Londoño-Lemos ME; Garza-Velasco R; Poblano-Meléndez I; Granada-Macías P; Gracia-Mora I; Barba-Behrens N
J Inorg Biochem; 2008; 102(5-6):1267-76. PubMed ID: 18304644
[TBL] [Abstract][Full Text] [Related]
49. Antiproliferative activity of 4-chloro-5,6-dihydro-2H-pyrans. Part 2: Enhancement of drug cytotoxicity.
León LG; Miranda PO; Martín VS; Padrón JI; Padrón JM
Bioorg Med Chem Lett; 2007 Jun; 17(11):3087-90. PubMed ID: 17398091
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, single crystal and antitumor activities of benzimidazole-quinazoline hybrids.
Sharma A; Luxami V; Paul K
Bioorg Med Chem Lett; 2013 Jun; 23(11):3288-94. PubMed ID: 23611732
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and characterization of 2-substituted benzimidazoles and their evaluation as anticancer agent.
Azam M; Khan AA; Al-Resayes SI; Islam MS; Saxena AK; Dwivedi S; Musarrat J; Trzesowska-Kruszynska A; Kruszynski R
Spectrochim Acta A Mol Biomol Spectrosc; 2015 May; 142():286-91. PubMed ID: 25706598
[TBL] [Abstract][Full Text] [Related]
52. Synthesis and biological evaluation of some 1,2-disubstituted benzimidazole derivatives as new potential anticancer agents.
Yurttaş L; Demirayak Ş; Çiftçi GA; Yıldırım ŞU; Kaplancıklı ZA
Arch Pharm (Weinheim); 2013 May; 346(5):403-14. PubMed ID: 23526768
[TBL] [Abstract][Full Text] [Related]
53. N-Hydroxy-1,2-disubstituted-1H-benzimidazol-5-yl acrylamides as novel histone deacetylase inhibitors: design, synthesis, SAR studies, and in vivo antitumor activity.
Wang H; Yu N; Song H; Chen D; Zou Y; Deng W; Lye PL; Chang J; Ng M; Sun ET; Sangthongpitag K; Wang X; Wu X; Khng HH; Fang L; Goh SK; Ong WC; Bonday Z; Stünkel W; Poulsen A; Entzeroth M
Bioorg Med Chem Lett; 2009 Mar; 19(5):1403-8. PubMed ID: 19181524
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and structure-activity relationships of N-aryl(indol-3-yl)glyoxamides as antitumor agents.
Marchand P; Antoine M; Le Baut G; Czech M; Baasner S; Günther E
Bioorg Med Chem; 2009 Sep; 17(18):6715-27. PubMed ID: 19682911
[TBL] [Abstract][Full Text] [Related]
55. Design, synthesis and pharmacological evaluation of new 3-(1H-benzimidazol-2-yl)quinolin-2(1H)-one derivatives as potential antitumor agents.
Kuang WB; Huang RZ; Qin JL; Lu X; Qin QP; Zou BQ; Chen ZF; Liang H; Zhang Y
Eur J Med Chem; 2018 Sep; 157():139-150. PubMed ID: 30092368
[TBL] [Abstract][Full Text] [Related]
56. Relaxant activity of 2-(substituted phenyl)-1H-benzimidazoles on isolated rat aortic rings: design and synthesis of 5-nitro derivatives.
Estrada-Soto S; Villalobos-Molina R; Aguirre-Crespo F; Vergara-Galicia J; Moreno-Díaz H; Torres-Piedra M; Navarrete-Vázquez G
Life Sci; 2006 Jun; 79(5):430-5. PubMed ID: 16487544
[TBL] [Abstract][Full Text] [Related]
57. Design, synthesis, and quantitative structure-activity relationship of cytotoxic gamma-carboline derivatives.
Chen J; Dong X; Liu T; Lou J; Jiang C; Huang W; He Q; Yang B; Hu Y
Bioorg Med Chem; 2009 May; 17(9):3324-31. PubMed ID: 19359185
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and QSAR evaluation of 2-(substituted phenyl)-1H-benzimidazoles and [2-(substituted phenyl)-benzimidazol-1-yl]-pyridin-3-yl-methanones.
Sharma D; Narasimhan B; Kumar P; Jalbout A
Eur J Med Chem; 2009 Mar; 44(3):1119-27. PubMed ID: 18657885
[TBL] [Abstract][Full Text] [Related]
59. Design, synthesis, and evaluation of novel kazusamycin A derivatives as potent antitumor agents.
Ando R; Amano Y; Nakamura H; Arai N; Kuwajima I
Bioorg Med Chem Lett; 2006 Jun; 16(12):3315-8. PubMed ID: 16617017
[TBL] [Abstract][Full Text] [Related]
60. Synthesis of novel 1,2,5-trisubstituted benzimidazoles as potential antitumor agents.
Abonia R; Cortés E; Insuasty B; Quiroga J; Nogueras M; Cobo J
Eur J Med Chem; 2011 Sep; 46(9):4062-70. PubMed ID: 21719162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
